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Abstract
Macrophages are important innate immune cells that respond to microbial insults. In response to multi-bacterial infection, the macrophage activation state may change upon exposure to nascent mediators, which results in different
bacterial killing mechanism(s). In this study, we utilized two respiratory bacterial pathogens, Mycobacterium bovis
(Bacillus Calmette Gu[rin, BCG) and Francisella tularensis live vaccine strain (LVS) with different phagocyte evasion
mechanisms, as model microbes to assess the influence of initial bacterial infection on the macrophage response to
secondary infection. Non-activated (M0) macrophages or activated M2-polarized cells ( J774 cells transfected with the
mouse IL-4 gene) were first infected with BCG for 24–48 h, subsequently challenged with LVS, and the results of
inhibition of LVS replication in the macrophages was assessed. BCG infection in M0 macrophages activated TLR2MyD88 and Mincle-CARD9 signaling pathways, stimulating nitric oxide (NO) production and enhanced killing of LVS.
BCG infection had little effect on LVS escape from phagosomes into the cytosol in M0 macrophages. In contrast, M2polarized macrophages exhibited enhanced endosomal acidification, as well as inhibiting LVS replication. Pre-infection
with BCG did not induce NO production and thus did not further reduce LVS replication. This study provides a model
for studies of the complexity of macrophage activation in response to multi-bacterial infection.
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Introduction
Our understanding of host–pathogen interaction is largely based on the host response to a single pathogen.
This approach has provided valuable information
about the action(s) taken by the host against invasion
by speciﬁc microbes and the mechanisms employed to
subvert the host immune system.1 However, many
human infections are now known to be polymicrobial
in nature (see the review by Bakaletz2). In such an
environment, immune responses triggered by one
pathogen may inﬂuence a host reaction to co-infecting
pathogens.1
During the initial stage of a host–pathogen interaction, the pathogen encounters strategically placed

phagocytic cells, e.g., macrophages that target and
eliminate infectious agents. Because macrophages may
encounter a variety of microbes, they are exposed to a
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multitude of stimulatory and suppressive signals that
may have a profound eﬀect on pathogen control. For
example, persistent infection with respiratory syncytial
virus in macrophages was shown to reduce the phagocytic capacity to engulf Haemophilus inﬂuenzae.3
Moreover, interaction with acidiﬁed Coxiella burnetii
phagolysosomes resulted in reduced growth of
Mycobacterium tuberculosis, which normally inhibits
phagolysosomal fusion.4 Additionally, resident M0
macrophages can be activated classically by Th1 cytokines (e.g., IFN-g) or alternatively by Th2 cytokines
(e.g., IL-4 and IL-13) to become phenotypically and
functionally distinct (M1 and M2, respectively) in
response to diﬀerent pathogens and environmental
insults, and such M1 and M2 macrophage populations
may vary under diﬀerent health conditions. For example, a signiﬁcant increase of M2 macrophages has been
reported in allergen-exposed mouse lungs,5 the lungs of
asthmatic patients,6 and of individuals exposed to cigarette smoke.7
Thus, this paper seeks to provide a model to
address the question of whether the outcome of
multi-bacterial infection is diﬀerent in M0 and M2
dominant microenvironments. For this purpose, we
used two well-characterized intracellular bacteria,
M. bovis BCG (Bacillus Calmette Gu[rin) and
Francisella tularensis live vaccine strain (LVS) as
model organisms because of diﬀerent outcomes in
the phagosome, i.e. BCG mainly resides in membrane-bound phagosomes while LVS rapidly escapes
to the cytosol.8 Both Mycobacterium and Francisella
can cause pulmonary infection and cervical lymphadenopathy. Although not the purpose of this study,
a recent survey of 1170 tuberculosis cervical lymphadenitis patients in Turkey (a country with emergent
endemic tularemia and epidemic tuberculosis) by
Karabay et al. found that 7% of these patients
were seropositive for F. tularensis.9
Previously, we have shown a novel IL-4 dependent
pathway that aids in reducing F. tularensis replication
in macrophages.10,11 IL-4-activated M2 macrophages,
subsequently infected with F. tularensis, exhibited
increased ATP levels and an associated increase in
phagosomal acidiﬁcation that led to a decrease in
F. tularensis phagosomal escape and reduced replication.10,11 In contrast, Mycobacterium infection results
in a dominant M1 polarization of alveolar macrophages during the ﬁrst 3 wk of infection.12 Taking
advantage of this established LVS-infected macrophage
system, and the well-characterized inhibitory mechanisms in M0 and M2 macrophages, we studied the inﬂuence of BCG on LVS infection in these two distinctly
diﬀerent macrophages. While both BCG and LVS
target and replicate inside macrophages, they possess
diﬀerent survival mechanisms. F. tularensis is a facultative, intracellular, Gram-negative bacterium that causes
the human disease tularemia.13 The LVS is a human
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attenuated strain derived from F. tularensis subsp.
holarctica14 that is often used as an experimental alternative in lieu of the more virulent subsp. tularensis15
and which, like F. tularensis, escapes from phagosomes
and replicates in high numbers in the cytosol.16 In contrast, BCG is an acid fast bacterium and vaccine strain
derived from multiple in vitro passages of M. bovis,
which arrests phagosomal maturation and fusion with
lysosomes and replicates within the phagosome.17
This phagosomal maturation arrest is crucial for the
persistence and replication of mycobacteria in
macrophages.18
Considering that LVS replicates much faster than
BCG and can kill infected macrophages between 48
and 72 h post-infection, we focused on studying the
eﬀects of pre-BCG infection-induced host modulation
on the subsequent endocytic traﬃcking and replication
of LVS. Distinct LVS killing mechanisms mediated by
BCG pre-infection in non-polarized and M2 polarized
macrophages are discussed and modeled.

Materials and methods
Mice
All animal experiments were performed in compliance
with the Animal Welfare Act, the U.S. Public Health
Service Policy on Humane Care and Use of Laboratory
Animals, and the ‘Guide for the Care and Use of
Laboratory Animals’ published by the National
Research Council. All animal work was done in accordance with the guidelines set forth by the University of
Texas at San Antonio Institutional Animal Care and
Use Committee, which speciﬁcally approved this study
under protocol IS00000029. Animals were euthanized
in a closed chamber with CO2 followed by cervical dislocation and all tissues were collected post-mortem.
Speciﬁc pathogen-free 4–8-wk-old mice were used for
all procedures. C57BL/6 mice were purchased from the
National Cancer Institute. TLR2/19 and TLR4/20
mice were provided by Dr M. T. Berton (UT Health
San Antonio).

Bacteria
F. tularensis LVS (obtained from Dr R. Lyons,
University of New Mexico and Dr Karen Elkins,
Food and Drug Administration) and F. tularensis
Schu S4 (obtained from the Centers for Disease
Control, CDC) were grown in tryptic soy broth supplemented with L-cysteine.21 Experiments using Schu S4
were conducted in a CDC-registered and annually certiﬁed Animal Biosafety Level 3 (ABSL-3) facility. M.
bovis BCG was obtained from Heartland National TB
Center and grown in Middlebrook 7H9 broth supplemented with Middlebrook Albumin Dextrose Complex
enrichment and 0.05% Tween 80.
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Generation of IL-4-expressing J774 cells
Standard molecular cloning methods were employed to
insert the mouse IL-4-encoding nucleotide sequence
into a pRetroX-Tight-Pur vector using the RetroXTM Tet-OnÕ Advanced Expression System, according to the manufacturer’s recommendation (Clontech).
The vector containing the IL-4 gene or vector alone was
used to transfect J774A.1 cells, and the resulting stable
cell lines containing either the IL-4 gene or vector alone
were designated as J774.IL4 and J774.vec, respectively.
IL-4 production in J774.IL4 cells is minimal but can be
induced with the addition of doxycycline. To determine
optimal induction, J774.IL4 cells were exposed to
increasing concentrations (25–100 ng/ml) of doxycycline for 4–12 h (data not shown). Based on the kinetics
of IL-4 production, we observed that a minimum of
50 ng/ml doxycycline was required for maximal IL-4
induction by 12 h, and thus this induction condition
was used throughout the study.

Cell culture and generation of primary cells for
infection
Cells (J774, J774.vec and J774.IL4) were cultured
at 37 C in complete DMEM with 4.5 g/l Gluc,
L-glutamine, sodium pyruvate and 10% FBS. Primary
macrophages were derived from C57BL/6 wild type
(WT), TLR2/ and TLR4/ mouse bone marrow
as previously described.10 Mincle/22, caspase recruitment domain family member 9-deﬁcient (CARD9/23)
and MyD88/ bone marrow were gifts from Dr Garry
Cole, University of Texas at San Antonio. For infection, J774, J774.vec and J774.IL4 cells were counted
and seeded (5  105/well in 24-well plates) in the presence of 50 ng/ml doxycycline for a period of 12 h. After
12 h, cells were infected with 10 MOI BCG for 48 h. At
the end of the BCG infection period, supernatants were
collected and ﬁltered. BCG-infected macrophages were
washed with DMEM and co-infected with 10 MOI LVS
suspended in the ﬁltered supernatants. LVS uptake and
replication were then measured at 3 and 24 h post-LVS
inoculation, by lysing infected macrophages with 0.2%
deoxycholate and determining the number of viable
LVS by serial dilution in sterile PBS and plating on
supplemented Tryptic Soy Agar plates.

Quantification of cytokines, NO and arginase activity
Cell supernatants were collected at the indicated time
points for assessment of IL-4 concentrations by ELISA,
according to the manufacturer’s recommendations (BD
Bioscience). Cells were lysed with 0.2% deoxycholate in
the presence of protease inhibitor (Roche Diagnostics)
for arginase activity measurement using the
QuantiChrom Arginase Assay Kit (Gentaur) and
reported as U/g (Units per gram of cell lysate protein).
NO was detected in culture supernatants using Griess
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reagent.24 In some experiments, the NO inhibitor
NG-monomethyl-L-arginine acetate salt (L-NMMA,
1.0 mM) was added at the time of doxycycline addition
and throughout the infection.25

Quantitation of cytosolic and total intracellular LVS
In order to assess escape of LVS from phagosomes to
the cytosol, we employed a diﬀerential membrane permeabilization method using digitonin and saponin.16,26
Brieﬂy, macrophages were seeded (5  105cells/well)
onto cover slips, induced with 50 ng/ml doxycycline
for 12 h and subsequently infected with 5  106 CFU
BCG, followed 48 h later by infection with LVS
(5  106 CFU). Cover slips were ﬁxed with 2% paraformaldehyde at indicated time points and treated with
50 mg/ml digitonin for 5 min at room temperature
(approx. 25 C) or with 2% saponin for 30 min at
room temperature. Cover slips without detergent treatment were used to determine surface LVS. Cover slips
were subsequently blocked using 1% BSA, 0.3 M glycine in PBS for 30 min at room temperature and then
incubated with rat anti-LVS primary Ab (generated in
our lab) for 2 h. Digitonin permeabilizes the plasma
membrane and allows Ab binding to the LVS only in
the cytosol. In contrast, saponin permeabilizes all the
membranes, including phagosomal membranes, allowing access to all intracellular LVS. Alexa Fluor
488-conjugated goat anti-rat IgG (H + L) (Life
Technologies) was used as a secondary Ab to label
LVS for 1 h. Cover slips were mounted using
FluroSave reagent (Calbiochem) and the presence of
the Alexa Fluor 488-labeled LVS was visualized using
a Zeiss LSM 510 confocal microscope. Total intracellular LVS was calculated by subtracting surface LVS
counts (sum of 25 randomly selected macrophages)
from saponin-treated samples (sum of 25 randomly
selected macrophages). Similarly, cytosolic LVS was
calculated by subtracting surface LVS from LVS
counts of digitonin-treated samples.

Statistics
Data were analyzed by Student’s t–test between the two
examined groups. A P value of 0.05 or less was considered statistically signiﬁcant. Data are representative
of experiments repeated at least twice.

Results
LVS replication is reduced in alternatively activated
(M2) J774 cells
Previously, we have demonstrated that mast cells inhibit F. tularensis replication in macrophages via IL-4
secretion.10,11 In order to study this bacterial inhibition
independent of mast cells, we generated the J774.IL4
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macrophage cell line, which is capable of producing IL4 upon doxycycline induction. As shown in Figure 1a,
IL-4 was produced in the J774.IL4 cells after 12 h doxycycline (50 ng/ml) induction but not in its absence. In
contrast, doxycycline did not induce IL-4 production in
J774 or J774.vec (J774 transfected with an empty
vector) cells. Increased arginase activity in J774.IL4
cells following doxycycline induction (Figure 1b) further suggested that these cells behaved in a similar fashion to that of an activated M2 phenotype.27 Although
there was no marked diﬀerence in cell morphology
among uninfected doxycycline-treated J774, J774.vec
and J774.IL4 cells (Figure 1c, upper panels), J774 and
J774.vec cells exhibited a more (38 and 13%, respectively) amoeboid-like shape with multiple pseudopodia
following 24 h LVS infection (Figure 1c, lower panels)
compared to infected J774.IL4 cells (less than 1% elongated cells), which were found to be more spherical in
shape, resembling non-infected macrophages. Similar
observations were reported in LVS-infected bone
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* ‡

0 ng/ml
50 ng/ml

300
200
100

(b)

Arginase (unit/g)

(a) 500

marrow-derived macrophages (BMMØ), which exhibited an increase in surface area, loss of sphericity,
elongation and decrease of volume due to apoptosis;10,11 while the presence of IL-4 (addition of
exogenous rIL-4 or co-culture with mast cells) led to
increased intramacrophage killing of LVS with restoration of spherical morphology. To assess the inhibitory
eﬀect of M2 J774.IL4 cells on LVS replication, macrophages were grown for 12 h in the presence of doxycycline, culture medium removed, and the cells infected
with LVS (10 MOI) for 3 h (bacterial uptake) and
24 h (replication) without doxycycline. As shown in
Figure 2a, bacterial uptake was comparable among
the three macrophage types; however, LVS replication
was signiﬁcantly reduced (approximately 1.5 log) in the
J774.IL4 compared to J774 and J774.vec cells.
Enhanced LVS inhibition in J774.IL4 cells correlated
with increased IL-4 production (Figure 2b) and arginase activity (Figure 2c), consistent with the M2 macrophage activation phenotype. Similarly, reduced growth
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Figure 1. Alternative activation of J774.IL-4 macrophages. J774, J774.vec or J774.IL4 cells were grown for 12 h in the presence
(50 ng/ml) or absence of DOX. IL-4 secretion (a) in culture media was measured by ELISA, cellular arginase activity (b) was determined
using the QuantiChrom Arginase Assay Kit, and cellular morphology (c) was visualized (400 phase contrast microscopy) 24 h after
LVS inoculation (10 MOI). *P < 0.05 between indicated groups. zP < 0.05 between the indicated J774.IL4 and respective J774 and
J774.vec groups.
BCG: Bacillus Calmette Gu[rin; DOX: doxycycline; LVS: live vaccine strain.
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Figure 2. F. tularensis replication in J774 cell lines. J774, J774.vec and J774.IL4 cells (5  105 per well) were incubated with doxycycline (50 ng/ml) for 12 h and subsequently infected with 5  106 LVS ((a) to (c)) or Schu S4 ((d) and (e)). Bacterial uptake and
replication were measured 3 h and 24 h post-inoculation ((a) and (d)). Additionally, the IL-4 concentration in culture media was
measured ((b) and (e)) and the cellular arginase activity was determined (C). zP < 0.05 between the indicated J774.IL4 and respective
J774 and J774.vec groups.
LVS: live vaccine strain.

of the human virulent strain F. tularensis Schu S4, associated with increased IL-4 levels, was observed in M2
J774.IL4 macrophages (Figure 2d and e).

BCG-mediated control of intramacrophage LVS
replication
In order to study how bacterial superinfection aﬀects
LVS replication, macrophages were infected with BCG
48 h prior to LVS infection. Using a GFP-expressing
BCG28,29 and an mCherry-expressing LVS30 for image
ﬂow cytometry assays (the Imagestream MKII, Amnis,
EMD Millipore),31 we estimated that 62% of J774 cells
were co-infected with BCG and LVS at 4 h post-LVS
inoculation. In addition, 4 and 23% of J774 cells harbored LVS and BCG alone, respectively (Figure 3a
to d). These results suggest that > 90% of LVS-infected
cells were pre-infected by BCG. It also was noted that
uptake of LVS by J774 cells, with or without pre-BCG
infection, was comparable (Figure 3e). Similarly, comparable rates (> 90%) of LVS infection were associated
with BCG pre-infection among doxycycline-treated
J774, J774.vec and J774.IL4 cells. Representative
images from ﬂow cytometric assays of these BCG–
LVS co-infected cells are shown in Figure 3f. A twofold
increase in cellular GFP intensity was observed in
BCG-infected J774.IL4, compared to J774 (and
J774.vec), cells, suggesting that M2 macrophages are

more susceptible to BCG infection, which is consistent
with other reports.32,33
It has been well documented that LVS escapes from
phagosomes within 30–60 min following phagocytosis
with resulting replication in the cytosol.13 Our data
are consistent with these observations, indicating that
in both J774 and J774.vec cells the cytosolic LVS numbers (macrophages permeabilized with digitonin) were
similar to the total intracellular LVS counts (macrophages permeabilized with saponin) following 1 and
4 h of LVS infection, respectively, suggesting that
most LVS had escaped from phagosomes by 1 h
(Figure 4a). In contrast, approximately 50% of LVS
remained in the phagosomes of doxycycline-activated
J774.IL4 (M2) cells at 4 h post-infection (Figure 4a).
Interestingly, pre-BCG infection (48 h) did not prevent
LVS escape from phagosomes in J774 and J774.vec
cells within 4 h (Figure 4b), but pre-infection with
BCG did result in the reduction of LVS replication at
24 h in macrophages compared to LVS infection alone
(Figure 4c). This BCG-mediated LVS inhibition
appears to be associated with NO production
(Figure 4d, J774 and J774.vec). Infection with BCG
12 h prior to LVS infection (time 0, Figure 4d, J774
and J774.vec) induced a signiﬁcant amount of
NO, which had minimal eﬀect on uptake of LVS
(Figure 4c, 3 h). However, increased NO production
(Figure 4d, comparing BCG + LVS to LVS alone)
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Figure 3. Uptake of BCG and LVS by J774 macrophage-like cells. Untreated J774 cells ((a) to (e)) or 50 ng/ml doxycycline-treated
J774, J774.vec and J774.IL4 cells (f ) were seeded (5  105/well in 24-well plates) for 12 h followed by infection with GFP-expressing
BCG (10 MOI) for 48 h, and subsequent inoculation with mCherry-expressing LVS (10 MOI). After 4 h incubation, co-infection with
BCG and LVS was visualized and frequency analyzed using the Imagestream MKII (Amnis, EMD Millipore). (a) The dot-plot depicts the
GFP and mCherry intensity of each cell and three gated cell populations: (b) mCherryhiGFPlow, (c) mCherryhiGFPhi and
(d) mCherrylowGFPhi. The representative cell images of these three gated populations are shown in (b) LVS-infected J774 cells,
(c) BCG–LVS co-infected cells (cellular localization of bacteria within this population was 93% using the Internalization Index analysis,
IDEASÕ ) and (d) BCG-infected cells. (e) Uptake of mCherry LVS by J774 cells was comparable between LVS alone (pink area) and
BCG + LVS co-infection (green line). (F) Shown are representative J774, J774.vec and J774.IL4 cells co-infected with BCG and LVS.
BCG: Bacillus Calmette Gu[rin; BF: Bright Field; LVS: live vaccine strain.

correlated with decreased LVS replication (Figure 4c,
24 h). In contrast, in M2 polarized J774.IL4 cells, preBCG infection did not reduce arginase production (data
not shown) nor induce NO production (Figure 4d), and
had little eﬀect on LVS escape (Figure 4a and b) and
replication (Figure 4c, LVS vs BCG + LVS).

Inhibition of intramacrophage LVS replication by BCG
was associated with NO production
To conﬁrm the essential role of NO in BCG-mediated
LVS inhibition, macrophages were treated with the NO
inhibitor L-NMMA. As shown in Figure 5a, BCG
infection signiﬁcantly elevated NO production in J774
and J774.vec cells as well as in BMMØs 48 h post-

inoculation, while addition of L-NMMA signiﬁcantly
abrogated NO production. We further assessed the role
of NO in suppression of LVS intramacrophage replication with LVS infection alone and pre-infection with
BCG. We observed that LVS infection alone induced
minimal NO in all three J774 cell lines and in BMMØs
(Figure 5b, upper panels). Consistent with previous
observations, LVS replication was signiﬁcantly reduced
in the M2 J774.IL4 macrophages in contrast to M0
J774 and J774.vec cells, and addition of the NO inhibitor L-NMMA had no eﬀect on LVS replication in
all three cell lines or in BMMØs (Figure 5b, lower
panels). However, when pre-infected with BCG,
LVS replication was inhibited in J774, J774.vec and
BMMØs (Figure 5b, lower panels), and this inhibition
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described in the Materials and methods. Concurrently, J774 cell lines (5  105 per well) were induced with doxycycline, infected with
BCG or mock treated with medium for 48 h, and infected with LVS. Uptake and replication of LVS were measured at 3 and 24 h postLVS inoculation (c), and NO levels in culture medium were measured prior to and 24 h after LVS inoculation using the Griess reagent
(d). *P < 0.05 between indicated groups. zP < 0.05 between the indicated J774.IL4 and respective J774 and J774.vec groups.
BCG: Bacillus Calmette Gu[rin; Dig: digoxin; LVS: live vaccine strain; Sap: saponin.

correlated with marked NO production (Figure 5b,
upper panels).
Additionally, inhibition of LVS was abrogated in the
presence of the NO inhibitor L-NMMA. These results
strongly suggest that BCG-mediated LVS inhibition is
NO-dependent in M0 macrophages. However, BCG and
NO have a minimal role in the control of LVS replication in M2 J774.IL4 cells (Figure 5b, lower left panel).

Activation of Mincle and TLR2 signaling is critical for
the control of LVS replication by BCG pre-infection
BCG has an atypical cell wall that contains ligands for
various PRRs. For example, lipoproteins, phosphatidylinositol mannans and lipomannan are all TLR2 ligands that are present on the surface of BCG.34 The
adaptor molecule for TLR2 signaling is MyD88,
which plays a central role in activation of the NF-kB
pathway and the production of pro-inﬂammatory cytokines.35 BCG also contains an unique glycolipid, trehalose 6,6’-dimycolate (TDM), which binds to C-type
lectin receptors such as Mincle that signal through the
adaptor protein CARD9 to stimulate inﬂammatory
responses.36 In order to determine if these PRR signaling components are essential for BCG-mediated NO-

dependent LVS inhibition, we generated BMMØs from
C57BL/6 Mincle, CARD9, TLR2 and MyD88 knockout mice. We also used C57BL/6 WT and TLR4/
BMMØs for comparison. In contrast to TLR2, TLR4
has been shown to play a minimal role in macrophage
activation by BCG.37 We infected BMMØs with BCG
for 48 h, measured NO levels in culture media, and
observed that deﬁciency of Mincle, CARD9, TLR2
and MyD88, but not TLR4, resulted in a signiﬁcant
reduction of NO production (Figure 6a), suggesting
that activation of Mincle-CARD9 and TLR2-MyD88
signaling was critical for BCG-induced NO production
in macrophages. Similar reductions of NO levels were
observed in BCG + LVS superinfected Mincle-,
CARD9-, TLR2- and MyD88-deﬁcient BMMØs
(Figure 6b), and these NO reductions correlated with
loss of BCG-mediated LVS inhibition in these four cell
types (Figure 6c). In contrast, TLR4 was not essential
in BCG-mediated LVS inhibition.

Discussion
In this study, we investigated the inﬂuence of pre-BCG
exposure in M0 or M2 polarized macrophages on subsequent LVS infection. Based upon our published
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Figure 5. NO-mediated control of LVS replication. J774, J774.vec and J774.IL-4 cells (1  106 per well) were induced with doxycycline (50 ng/ml, 12 h). BMMØs derived from C57BL/6 mice were infected with BCG (1  107) in the presence or absence of NO
inhibitor L-NMMA, and NO levels in culture media measured 24 h post-inoculation (a). In a similar study, BMMØs and doxycyclineinduced J774 cell lines were infected with BCG, or mock treated with medium in the presence or absence of L-NMMA for 48 h, and
infected with LVS. NO concentration ((b), upper panel) and LVS replication ((b), lower panel) were measured 24 h post-LVS inoculation. *P < 0.05 between indicated groups. zP < 0.05 between the indicated J774.IL4 and respective J774 and J774.vec groups.
BCG: Bacillus Calmette Gu[rin; BMMØ: bone marrow-derived macrophages; L-NMMA: NG-monomethyl-L-arginine acetate salt; LVS:
live vaccine strain.

observations of IL-4-mediated LVS inhibition10,11 and
data obtained from this study, we propose a model
(Figure 7) exhibiting the two distinct defense mechanisms by which macrophages control LVS infection.
When the M0 J774 and BMMØ cells are infected with
BCG, their surface PPRs, i.e. TLR2 and Mincle, may
recognize respective ligands (e.g. liproproteins and
TDM) from BCG and subsequently activate NF-kB
through the MyD88 and CARD9 adaptors. Activation
of NF-kB may then up-regulate inducible NO synthase
(iNOS) gene transcription and protein expression,
resulting in increased NO production. Subsequent
LVS infection of BCG-activated macrophages allows
most LVS to escape from phagosomes followed by elimination via NO-mediated killing. In contrast, in M2
J774.IL4 macrophages, IL-4 may upregulate arginase
(ARG1) gene transcription and protein expression via
IL-4 R binding and STAT6 phosphorylation.38 The
induced arginase converts arginine to ornithine, a precursor of polyamines and hydroxyproline that induces
cell proliferation and collagen production.39 Because of

the high ARG1 activity in M2-polarized J774.IL4 cells,
minimal arginine, the common substrate for iNOS and
ARG1, is available for conversion to L-hydroxy-arginine by BCG induced iNOS, with resulting minimal
NO production following BCG infection. During subsequent LVS infection in M2 macrophages with prior
BCG exposure, fewer LVS escape from the phagosome
into the cytosol, and the macrophages control LVS
growth by enhancing ATP production and phagosomal
acidiﬁcation as previously reported.11 In contrast,
reduction of LVS replication in M2 J774.IL4 is independent of BCG activation during BCG–LVS
superinfection.
Both BCG and LVS can evade the endosomal–lysosomal degradation pathway, but by diﬀerent mechanisms. Following phagocytosis, typical pathogencontaining phagosomes acquire markers such as Rab5
(a small GTPase) and EEA1 (early endosomal antigen
1), which directs the fusion of phagosomes with early
endosomal vesicles.40 Endosomes continue to mature
into late endosomes by replacing Rab5 with Rab7, and
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Figure 6. Innate signaling is required for BCG-mediated LVS inhibition during BCG–LVS superinfection. BMMØs prepared from WT
C57BL6 and various gene-deficient mice, including Mincle, CARD9, TLR2, TLR4 and MyD88, were infected with BCG for 48 h and NO
production was measured (a). Similarly prepared BMMØs were infected with LVS for 24 h with (BCG + LVS) or without (mock + LVS)
prior BCG (48 h) infection, and the NO levels in culture medium (b) and viable LVS within macrophages (c) were analyzed. *P < 0.05
between indicated groups. zP < 0.05 between the indicated gene-deficiency and WT groups.
BCG: Bacillus Calmette Gu[rin; BMMØ: bone marrow-derived macrophages; CARD9: caspase recruitment domain family member 9;
LVS: live vaccine strain; WT, wild type.

become acidiﬁed after the acquisition of vacuolar
proton-ATPase molecules, eventually fusing with lysosomes for ultimate pathogen degradation. In the case of
F. tularensis uptake by macrophages, the bacteriumcontaining phagosome matures into early and late endosomes, but fails to become acidiﬁed. Non-acidiﬁed late
endosome-like phagosomes containing F. tularensis do
not fuse with lysosomes and allow the bacteria to
escape into the cytoplasm following gradual disruption
of the vesicle.8 However, in J774.IL4 cells, IL-4 activation most likely enhances endosomal acidiﬁcation, as
suggested by our previous studies,11 improving LVS killing. Conversely, BCG phagosomes acquire some endosomal markers such as Rab 5, but do not mature into
late endosomes by preventing Rab5/Rab7 conversion,
and BCG replicates in these arrested vesicles.17,41
However, pre-infection with BCG appears to have
little eﬀect on LVS escape from the endosomes in both
J774 and BMMØs.
It should be noted that the results presented here
were obtained from a population of macrophages preinfected with BCG and then infected with LVS. We
have not speciﬁcally investigated the macrophages
during simultaneous co-infection with both BCG and
LVS. However, > 90% of LVS-infected cells were pre-

infected with BCG (Figure 3). Thus, the observed LVS
replication was a collective outcome from BCG preinfected macrophages and single LVS-infected macrophages activated by BCG-induced secretory factors. A
mixture of singly and multi-infected macrophages may
exist in naturally occurring co-infection. Furthermore,
our results imply a complexity of disease outcome via
pre-infection due to the plasticity and dynamics of
macrophage phenotypes in the infection compartment.
It also needs to be noted that experiments conducted in
this study also used BMMØ but not the more disease
relevant alveolar macrophages (ALVM); however, we
have compared rat BMMØ and ALVM and demonstrated comparable Francisella replication in these
two types of macrophages.42 Additional studies using
mouse ALVM are required to conﬁrm the similar
mechanisms of BCG-mediated inhibition of LVS replication that were observed in BMMØ and J774 cells.
In summary, we have provided evidence of BCGmediated suppression of LVS replication using an
in vitro macrophage infection model and have further
characterized the mechanisms of LVS killing by M0,
M1 (equivalent to BCG infection alone) and M2
macrophage phenotypes. Additionally, we have
answered the question of whether an M1 polarizing
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pathogen inﬂuences the outcome of secondary infection
in already M2 polarized macrophages by altering the
bacterial killing mechanism(s). However, the eﬀect of
BCG on pneumonic tularemia in animals following
superinfection remains to be elucidated. In this
regard, mycobacterium-mediated protection against
lethal malaria infection in a co-infection mouse model
has been demonstrated.43
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